Unknown

Dataset Information

0

LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in Hepatocytes.


ABSTRACT: BACKGROUND:Hepatitis C virus infection is one of the leading causes of end stage liver diseases. The innate immune response slows down viral replication by activating cytokines such as type I interferon (IFN-?/?), which trigger the synthesis of antiviral proteins and modulate the adaptive immune system. Recently, leucine-rich repeat (in Flightless I) interacting protein-1 (LRRFIP1) was reported contributing to the production of interferon-? in macrophages. OBJECTIVES:The aim of this study was to assess the role of LRRFIP1 in induction of IFN-? and inhibition of HCV infection in hepatocytes. MATERIALS AND METHODS:Induction of IFN-? by LRRFIP1 in Huh7 and Huh7.5.1 was determined by real-time PCR and western blotting in vitro. Inhibition of HCV replication by LRRFIP1 overexpression in hepatocytes was assessed. RESULTS:LRRFIP1 increased the expression of IFN-? in hepatocytes with or without HCV infection. Induction of IFN-? by LRRFIP1 was enhanced with the presence of hepatitis C virus. Overexpression of LRRFIP1 in hepatocytes inhibited HCV replication. However, HCV infection did not regulate intracellular expression of LRRFIP1. CONCLUSIONS:LRRFIP1 and its mediated production of type I interferon play a role in controlling HCV infection. The findings of this study provide new target for HCV treatment and contribute to development of anti-HCV drugs.

SUBMITTER: Liu Y 

PROVIDER: S-EPMC4451274 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in Hepatocytes.

Liu Yuan Y   Zou Ziying Z   Zhu Bing B   Hu Zonghai Z   Zeng Ping P   Wu Lijuan L  

Hepatitis monthly 20150523 5


<h4>Background</h4>Hepatitis C virus infection is one of the leading causes of end stage liver diseases. The innate immune response slows down viral replication by activating cytokines such as type I interferon (IFN-α/β), which trigger the synthesis of antiviral proteins and modulate the adaptive immune system. Recently, leucine-rich repeat (in Flightless I) interacting protein-1 (LRRFIP1) was reported contributing to the production of interferon-β in macrophages.<h4>Objectives</h4>The aim of th  ...[more]

Similar Datasets

| S-EPMC104078 | biostudies-literature
| S-EPMC140855 | biostudies-literature
| S-EPMC4252895 | biostudies-other
| S-EPMC4604411 | biostudies-literature
| S-EPMC7113783 | biostudies-literature
| S-EPMC3581145 | biostudies-literature
| S-EPMC9354525 | biostudies-literature
2021-07-26 | PXD022271 | Pride
| S-EPMC4584467 | biostudies-literature
| S-EPMC3642163 | biostudies-literature